Você está em: Start > Publications > Lapatinib-capecitabine versus capecitabine alone as radiosensitizers in RAS wild-type resectable rectal cancer, an adaptive randomized phase II trial (LaRRC trial): study protocol for a randomized controlled trial > View related publications
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto
I Terms and Conditions
I Acessibility
I Index A-Z
Page created on: 2025-11-12 at 09:42:25 | Privacy Policy | Personal Data Protection Policy | Whistleblowing | Electronic Yellow Book
Page created on: 2025-11-12 at 09:42:25 | Privacy Policy | Personal Data Protection Policy | Whistleblowing | Electronic Yellow Book